International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Exp Ther Med 22:[Related article:] 1430, 2021; DOI: 10.3892/etm.2021.10865
Following the publication of this article, the authors regret that the paper contained some errors that should have been corrected before the article went to press. First, in the Materials and methods section, “miRNA transfection” subsection, on p. 2, right-hand column, line 6, the text “miR-505-3p mimics (5’-GGGAGCCAGGAACGAUUGAUGU-3’), inhib-itor (5’-ACUACUGAGCCGCAGUAGA-3’)” should have been written as “miR-506-3p mimics (5’-UAAGGCACCC-UUCUGAGUAGA-3’), inhibitor (5’-UCUACUCAGA-AGGGUGCCUUA-3’)”. Secondly, the authors have subsequently realized that certain of the primer sequences featured in Table I were written erroneously; specifically, the sequences for SREBP1, FASN, SCD1 and ACC1. A corrected version of Table I is shown opposite, where the proper sequences for SREBP1, FASN, SCD1 and ACC1 are shown, highlighted in bold.
The authors are grateful to the Editor of Experimental and Therapeutic Medicine for allowing them the opportunity to publish this corrigendum, and allt he authors agree with its publication. The authors also regret any inconvenience that this mistake has caused.